Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

Ethereum, Filecoin, Chainlink, and many other billion-dollar cryptocurrencies raised funds via ICO campaigns, so this investment niche can be lucrative. So, let’s get acquainted with the top ...

Apart from reviewing some of the top ICO cryptos currently in existence, we’ll also examine some upcoming ICOs and tackle the inherent risks and rewards of such early-stage investments.

Tokens created by the firm are sold to investors for cryptocurrency or fiat money in an ICO. These tokens may or may not be a representation of a stake in the corporation, but they may be sold on ...

You could lose all of your capital. An initial coin offering, or ICO, is a popular way for crypto projects to generate publicity and raise capital. Much like crowdfunding, ICOs allow the community to ...

1 Day CON 0.52% DJIA 0.09% S&P Mid Cap 400 0.01% Health Care/Life Sciences 0.22% ...